TOLFEDINE 4 % W/V SOLUTION FOR INJECTION FOR DOGS AND CATS

Ülke: İrlanda

Dil: İngilizce

Kaynak: HPRA (Health Products Regulatory Authority)

şimdi satın al

Ürün özellikleri Ürün özellikleri (SPC)
29-08-2015

Aktif bileşen:

TOLFENAMIC ACID

Mevcut itibaren:

Vetoquinol Ireland Limited

ATC kodu:

QM01AG02

INN (International Adı):

TOLFENAMIC ACID

Doz:

4 %w/v

Farmasötik formu:

Solution for Injection

Reçete türü:

POM

Terapötik grubu:

Canine, Feline

Terapötik alanı:

Tolfenamic acid

Terapötik endikasyonlar:

N.S.A.I.D

Yetkilendirme durumu:

Authorised

Yetkilendirme tarihi:

1993-08-12

Ürün özellikleri

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Tolfedine 4% w/v Solution for Injection for dogs and cats
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Sterile solution for injection
A clear colourless to slightly yellow sterile aqueous solution
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs, Cats
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
IN DOGS : inflammatory and painful post operative syndromes
IN CATS : adjuvant treatment of upper respiratory disease in association with antimicrobial therapy
4.3 CONTRAINDICATIONS
Tolfenamic acid is contra-indicated in case of cardiac disease
Do not use in animals with impaired hepatic function or acute renal insufficiency
Tolfenamic acid is contra-indicated in case of ulceration or digestive bleeding, in case of blood dyscrasia or
hypersensitivity to tolfenamic acid.
Do not inject intramuscularly in cats.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
NSAIDS can cause inhibition of phagocytosis and hence in the treatment of inflammatory conditions associated with
bacterial infections appropriate concurrent antimicrobial therapy should be instigated
The use of insulin-type needle/syringe is advisable particularly in low-weight animals to ensure an accurate dose.
Each ml contains
ACTIVE SUBSTANCE
Tolfenamic acid
40 mg
EXCIPIENTS
Benzyl alcohol
10.4 mg
Sodium formaldehyde sulfoxylate
5 mg
For a full list of excipients see section 6.1
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 14/08/2015_
_CRN 7021600_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
(I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Use in animals less than 6 weeks of age, or in aged animals, may involve additional risk. If such a us
                                
                                Belgenin tamamını okuyun
                                
                            

Bu ürünle ilgili arama uyarıları